Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Gastroenterology Clinics of North America
|
June 5, 2004
Methotrexate in inflammatory bowel disease
Brian G Feagan, Ahmad Alfadhli
Vaccines
|
July 27, 2022
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli
Infection Prevention in Practice
|
July 28, 2021
Effectiveness of inspectors' team in increasing compliance with personal protective equipment use and reducing COVID19 infection spread among healthcare workers
Mohammad Shehab, Sameera Shuaibi, Iman Qadhi, et al.
Frontiers in Pharmacology
|
October 25, 2023
Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)
Fatema Alrashed, Israa Abdullah, Ahmad Alfadhli, et al.
Medicine
|
July 5, 2024
Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn's disease: A multi-center nationwide retrospective study (TARGET STUDY)
Mohammad Shehab, Israa Abdullah, Ahmad Alfadhli, et al.
Journal of Global Infectious Diseases
|
October 14, 2022
A Randomized Clinical Trial Comparing Triple Therapy versus Non-bismuth based Quadruple Therapy for the Eradication of <i>Helicobacter Pylori</i> in Kuwait
Ahmad Alfadhli, Mohamed Alboraie, Mostafa Afifi, et al.
Diagnostics (Basel, Switzerland)
|
November 9, 2024
Predictive Factors of Significant Findings on Capsule Endoscopy in Patients with Suspected Small Bowel Bleeding
Ali A Alali, Reem Alrashidi, Farah Allahow, et al.
Vaccines
|
January 22, 2022
COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study
Mohammad Shehab, Yasmin Zurba, Ali Al Abdulsalam, et al.
Frontiers in Pharmacology
|
October 31, 2024
Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)
Mohammad Shehab, Ahmad Alfadhli, Israa Abdullah, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 13, 2025
Relationship Between Patient Demographics and Biologic Therapy Use in Inflammatory Bowel Disease. A Single Center Cross-Sectional Study
Mohammad Shehab, Abdulwahab Alsayegh, Munirah Alabdulhadi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Gastroenterology Clinics of North America
|
June 5, 2004
Methotrexate in inflammatory bowel disease
Brian G Feagan, Ahmad Alfadhli
Vaccines
|
July 27, 2022
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli
Infection Prevention in Practice
|
July 28, 2021
Effectiveness of inspectors' team in increasing compliance with personal protective equipment use and reducing COVID19 infection spread among healthcare workers
Mohammad Shehab, Sameera Shuaibi, Iman Qadhi, et al.
Frontiers in Pharmacology
|
October 25, 2023
Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)
Fatema Alrashed, Israa Abdullah, Ahmad Alfadhli, et al.
Medicine
|
July 5, 2024
Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn's disease: A multi-center nationwide retrospective study (TARGET STUDY)
Mohammad Shehab, Israa Abdullah, Ahmad Alfadhli, et al.
Journal of Global Infectious Diseases
|
October 14, 2022
A Randomized Clinical Trial Comparing Triple Therapy versus Non-bismuth based Quadruple Therapy for the Eradication of <i>Helicobacter Pylori</i> in Kuwait
Ahmad Alfadhli, Mohamed Alboraie, Mostafa Afifi, et al.
Diagnostics (Basel, Switzerland)
|
November 9, 2024
Predictive Factors of Significant Findings on Capsule Endoscopy in Patients with Suspected Small Bowel Bleeding
Ali A Alali, Reem Alrashidi, Farah Allahow, et al.
Vaccines
|
January 22, 2022
COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study
Mohammad Shehab, Yasmin Zurba, Ali Al Abdulsalam, et al.
Frontiers in Pharmacology
|
October 31, 2024
Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)
Mohammad Shehab, Ahmad Alfadhli, Israa Abdullah, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 13, 2025
Relationship Between Patient Demographics and Biologic Therapy Use in Inflammatory Bowel Disease. A Single Center Cross-Sectional Study
Mohammad Shehab, Abdulwahab Alsayegh, Munirah Alabdulhadi, et al.
Page
of 3